Business Context and Reporting Period
This Form 8-K filing by IRADIMED CORP was submitted on September 24, 2018, reporting events occurring between September 14, 2018 and September 21, 2018. The report focuses exclusively on Item 5.02 regarding the departure, election, or appointment of certain officers and their compensatory arrangements.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to executive compensation details.
Material Changes and Executive Compensation
The Company executed three employment-related agreements during the reporting period:
- John McCreery (Chief Operating Officer): Entered into an employment agreement modification on September 14, 2018. His annual bonus target was increased from 30% to 50% of his base salary. The bonus remains subject to adjustment based on Company profitability and individual performance.
- Louis Waldman (Controller): Entered into a new employment agreement on September 18, 2018. His annual base salary is set at $181,670. He is eligible for an annual bonus based on profitability and performance. The agreement includes a severance provision of six months' base salary if terminated without cause or if he resigns for good reason.
- Francis Casey (Vice President of Regulatory and Quality Assurance): Entered into a new employment agreement on September 21, 2018. His annual base salary is set at $158,912. He is eligible for an annual bonus based on profitability and performance. The agreement includes a severance provision of six months' base salary if terminated without cause or if he resigns for good reason.
All new agreements include standard non-solicitation, non-compete, and confidentiality provisions.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies are disclosed beyond the standard contractual terms of the employment agreements.
Investor Verification Checklist
- Review Exhibit 10.1 for the full text of the COO's bonus modification and performance metrics.
- Review Exhibit 10.2 and Exhibit 10.3 to verify the specific definitions of "good reason" and "without cause" for the Controller and VP of Regulatory and Quality Assurance.
- Confirm the total annual compensation cost impact of the new hires and the COO's bonus increase against the Company's current profitability.